|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/17/11 JPMorgan Chase & Co. NO ACT 1/10/11 1:2K SEC #7
2/17/11 JPMorgan Chase & Co. NO ACT 1/10/11 1:2K SEC #7
2/17/11 RK Capital Management, LLC 13FCONP 9/30/08 1:2K SEC #7
2/17/11 RK Capital Management, LLC 13FCONP 6/30/08 1:2K SEC #7
2/17/11 RK Capital Management, LLC 13FCONP 3/31/08 1:2K SEC #7
2/17/11 Boston Partners 13FCONP 9/30/08 1:2K SEC #7
2/17/11 BCS Americas, Inc. X-17A-5 12/31/10 1:2K SEC #7
2/17/11 RK Capital Management, LLC 13FCONP 9/30/09 1:2K SEC #7
2/17/11 RK Capital Management, LLC 13FCONP 3/31/09 1:2K SEC #7
2/17/11 RK Capital Management, LLC 13FCONP 12/31/08 1:2K SEC #7
2/17/11 Boston Partners 13FCONP 9/30/07 1:2K SEC #7
2/17/11 Boston Partners 13FCONP 6/30/07 1:2K SEC #7
2/17/11 Boston Partners 13FCONP 3/31/07 1:2K SEC #7
2/17/11 Fli Investors, LLC X-17A-5 12/31/10 1:2K SEC #7
2/17/11 Cboe BYX Exchange, Inc. 19B-4E 2/17/11 1:2K SEC #7
2/17/11 Cboe BZX Exchange, Inc. 19B-4E 2/17/11 1:2K SEC #7
2/17/11 Kalorama Capital, LLC X-17A-5 12/31/10 1:2K SEC #7
2/17/11 Everence Securities, Inc. FOCUSN 12/31/10 1:2K SEC #7
2/17/11 Setter Capital Inc. FOCUSN 12/31/10 1:2K SEC #7
2/17/11 Atel Securities Corp. FOCUSN 12/31/10 1:2K SEC #7
____________ | ¹ | Filing/Form Types: | | 13FCONP | Quarterly Holdings and Combination Report by a Money Manager – Confidential Treatment Requested — Form 13F. | | 19B-4E | Info from a Self-Regulatory Organization (SRO) Listing and Trading a New Derivative Securities Product — Form 19b-4(e). | | FOCUSN | Annual Audit Report on a Financial Report [ a.k.a. FOCUS Report ] by a Broker or Dealer. | | NO ACT | SEC No-Action Letter re: a Shareholder Proposal. | | X-17A-5 | Annual Financial Report [ a.k.a. FOCUS Report ] by a Broker or Dealer — Form X-17A-5. |
|